These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 12604605)
41. Perlecan functions in chondrogenesis: insights from in vitro and in vivo models. Gomes RR; Farach-Carson MC; Carson DD Cells Tissues Organs; 2004; 176(1-3):79-86. PubMed ID: 14745237 [TBL] [Abstract][Full Text] [Related]
42. Extracellular matrix protein 1 (ECM1) has angiogenic properties and is expressed by breast tumor cells. Han Z; Ni J; Smits P; Underhill CB; Xie B; Chen Y; Liu N; Tylzanowski P; Parmelee D; Feng P; Ding I; Gao F; Gentz R; Huylebroeck D; Merregaert J; Zhang L FASEB J; 2001 Apr; 15(6):988-94. PubMed ID: 11292659 [TBL] [Abstract][Full Text] [Related]
43. Mapping of the binding of platelet-derived growth factor to distinct domains of the basement membrane proteins BM-40 and perlecan and distinction from the BM-40 collagen-binding epitope. Göhring W; Sasaki T; Heldin CH; Timpl R Eur J Biochem; 1998 Jul; 255(1):60-6. PubMed ID: 9692901 [TBL] [Abstract][Full Text] [Related]
44. Human basement membrane heparan sulfate proteoglycan core protein: a 467-kD protein containing multiple domains resembling elements of the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. Kallunki P; Tryggvason K J Cell Biol; 1992 Jan; 116(2):559-71. PubMed ID: 1730768 [TBL] [Abstract][Full Text] [Related]
45. Perlecan inhibits smooth muscle cell adhesion to fibronectin: role of heparan sulfate. Lundmark K; Tran PK; Kinsella MG; Clowes AW; Wight TN; Hedin U J Cell Physiol; 2001 Jul; 188(1):67-74. PubMed ID: 11382923 [TBL] [Abstract][Full Text] [Related]
46. Perlecan, the multidomain heparan sulfate proteoglycan of basement membranes, is also a prominent component of the cartilaginous primordia in the developing human fetal spine. Melrose J; Smith S; Ghosh P; Whitelock J J Histochem Cytochem; 2003 Oct; 51(10):1331-41. PubMed ID: 14500701 [TBL] [Abstract][Full Text] [Related]
47. Cell surface chondroitin sulphate proteoglycan 4 (CSPG4) binds to the basement membrane heparan sulphate proteoglycan, perlecan, and is involved in cell adhesion. Tang F; Lord MS; Stallcup WB; Whitelock JM J Biochem; 2018 May; 163(5):399-412. PubMed ID: 29462330 [TBL] [Abstract][Full Text] [Related]
48. Suppression of invasive behavior of melanoma cells by stable expression of anti-sense perlecan cDNA. Adatia R; Albini A; Carlone S; Giunciuglio D; Benelli R; Santi L; Noonan DM Ann Oncol; 1997 Dec; 8(12):1257-61. PubMed ID: 9496392 [TBL] [Abstract][Full Text] [Related]
49. Basement membrane proteoglycans are of epithelial origin in rodent skin. Yamane Y; Yaoita H; Couchman JR J Invest Dermatol; 1996 Mar; 106(3):531-7. PubMed ID: 8648189 [TBL] [Abstract][Full Text] [Related]
50. Perlecan, A Multi-Functional, Cell-Instructive, Matrix-Stabilizing Proteoglycan With Roles in Tissue Development Has Relevance to Connective Tissue Repair and Regeneration. Hayes AJ; Farrugia BL; Biose IJ; Bix GJ; Melrose J Front Cell Dev Biol; 2022; 10():856261. PubMed ID: 35433700 [TBL] [Abstract][Full Text] [Related]
51. Extracellular matrix histone H1 binds to perlecan, is present in regenerating skeletal muscle and stimulates myoblast proliferation. Henriquez JP; Casar JC; Fuentealba L; Carey DJ; Brandan E J Cell Sci; 2002 May; 115(Pt 10):2041-51. PubMed ID: 11973346 [TBL] [Abstract][Full Text] [Related]
53. Review of Alterations in Perlecan-Associated Vascular Risk Factors in Dementia. Trout AL; Rutkai I; Biose IJ; Bix GJ Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31968632 [TBL] [Abstract][Full Text] [Related]
54. The relationship between perlecan and dystroglycan and its implication in the formation of the neuromuscular junction. Peng HB; Ali AA; Daggett DF; Rauvala H; Hassell JR; Smalheiser NR Cell Adhes Commun; 1998 Sep; 5(6):475-89. PubMed ID: 9791728 [TBL] [Abstract][Full Text] [Related]
55. Lipoprotein modulation of subendothelial heparan sulfate proteoglycans (perlecan) and atherogenicity. Pillarisetti S Trends Cardiovasc Med; 2000 Feb; 10(2):60-5. PubMed ID: 11150731 [TBL] [Abstract][Full Text] [Related]
56. Developmental expression of perlecan during murine embryogenesis. Handler M; Yurchenco PD; Iozzo RV Dev Dyn; 1997 Oct; 210(2):130-45. PubMed ID: 9337134 [TBL] [Abstract][Full Text] [Related]
57. Mapping of binding sites for nidogens, fibulin-2, fibronectin and heparin to different IG modules of perlecan. Hopf M; Göhring W; Mann K; Timpl R J Mol Biol; 2001 Aug; 311(3):529-41. PubMed ID: 11493006 [TBL] [Abstract][Full Text] [Related]